184 related articles for article (PubMed ID: 34922358)
1. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
[TBL] [Abstract][Full Text] [Related]
2. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
[TBL] [Abstract][Full Text] [Related]
3. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
4. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.
Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
World J Gastroenterol; 2013 Dec; 19(45):8312-20. PubMed ID: 24363522
[TBL] [Abstract][Full Text] [Related]
5. Gastrinoma--morphological aspects.
Klöppel G; Anlauf M
Wien Klin Wochenschr; 2007; 119(19-20):579-84. PubMed ID: 17985091
[TBL] [Abstract][Full Text] [Related]
6. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
7. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
[TBL] [Abstract][Full Text] [Related]
8. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE; Elvevi A; Citterio D; Coppa J; Invernizzi P; Mazzaferro V; Massironi S
World J Gastroenterol; 2021 Sep; 27(35):5890-5907. PubMed ID: 34629807
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
10. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.
Wada M; Komoto I; Doi R; Imamura M
World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).
van Beek DJ; Nell S; Pieterman CRC; de Herder WW; van de Ven AC; Dekkers OM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
J Surg Oncol; 2019 Nov; 120(6):966-975. PubMed ID: 31401809
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
13. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.
Imamura M; Komoto I; Ota S; Hiratsuka T; Kosugi S; Doi R; Awane M; Inoue N
World J Gastroenterol; 2011 Mar; 17(10):1343-53. PubMed ID: 21455335
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
Banasch M; Schmitz F
Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
[TBL] [Abstract][Full Text] [Related]
15. Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.
Massironi S; Rossi RE; Laffusa A; Eller-Vainicher C; Cavalcoli F; Zilli A; Ciafardini C; Sciola V; Invernizzi P; Peracchi M
J Endocrinol Invest; 2023 May; 46(5):957-965. PubMed ID: 36436191
[TBL] [Abstract][Full Text] [Related]
16. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
18. Selective arterial stimulation of secretin in localization of gastrinomas.
Rosato FE; Bonn J; Shapiro M; BarBot DJ; Furnary AM; Gardiner GA
Surg Gynecol Obstet; 1990 Sep; 171(3):196-200. PubMed ID: 2166970
[TBL] [Abstract][Full Text] [Related]
19. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of the secretin provocation test.
Lamers CB
J Clin Gastroenterol; 1981 Sep; 3(3):255-9. PubMed ID: 7288118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
